Retour aux projets

13877.1;10 PFLS-LS

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Résumé

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Textes supplémentaires

Abstract

Non-invasive, nuclear imaging techniques such as positron emission tomography (PET) are crucial for cancer diagnosis, treatment planning and monitoring. The folate receptor (FR) is a promising cancer-related target because of its overexpression in a wide variety of tumor types. We will test the first PET-folate tracer in a pilot study in patients. The novel radiotracer is expected to be of major clinical and health economical relevance as it serves for diagnostic purposes and also for identification of patients, who may profit from FR-targeting therapies.

Participants

Roger Schibli

Kontaktperson

roger.schibli@pharma.ethz.ch

ETH Zürich Roger Schibli Wolfgang-Pauli-Strasse 10 Institute of Pharmaceutical Science 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-08-31
Date de fin
2015-11-11
Coûts totaux approuvés
CHF 142080.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • P004 Biochemistry, Metabolism 100.0%